Abstract:Objective To investigate the expression of αVβ3 integrin and platelet endothelial cell adhesion molecule-1 (CD31) in progressive liver fibrosis of rats. Methods Sixty-four SD rats were randomly divided into 4 equal groups: TAA group, undergoing peritoneal injection of 10% thioacetamine (TAA) 175 mg/kg twice a week to induce liver fibrosis, TAA control group undergoing peritoneal injection of normal saline (NS), BDL group undergoing ligation and resection of common bile duct to induce liver fibrosis, and BDL control group undergoing sham operation. Three and 9 weeks later 2 rats from the 2 TAA groups and 1 and 4 weeks later 2 rats from the 2 BDL groups were killed with their liver taken out to undergo sirius red staining and computer image analysis to observe the area of fibrosis. Immuuohistochemistry was used to detect the expression of αVβ3 integrin and CD31. The co-location of αVβ3 integrin and α-smooth muscle antibody (SMA) in the liver tissues was observed by immunohistochemical and double immunofluorescence staining. Real-time PCR and Western blotting were used to examine the mRNA and protein expression of αVβ3 integrin and CD31. Results The sirius red stained areas 3 and 9 weeks later of the TAA group were 5.8%±1.2% and 16.5%±3.6% respectively, and the sirius red stained areas 1 and 4 weeks later of the BDL group were 6.6% ±1.6% and 18.5% ±4.5% respectively. Immunohistochemical and double immunofluorescence staining showed that there was an overlapping of αVβ3 and α-SMA expression. Expression of CD31 was extended in the endothelial ceils and portal area of both models, and new blood vessels were seen in the fibrotic septum and among the hyperplastic bile ducts. The levels of αVβ3 and CD31 mRNA expression of the TAA and BDL groups were both upregulated (F = 28.66, P＜0.01,F=19.62, P＜0.01 and F=32.60, P＜0.01, F=42.36, P＜0.01 respectively) and were increased along with the degree of fibrosis. The levels of protein expression of αVβ3 and CD31 showed the similar trend of their mRNA expression. Conclusion The levels of αVβ3 integrin and CD31 expression are upregulated in liver fibrotic tissue. Such overexpression is involved in the activation of hepatic stellate cells and angiogenesis that correspond with fibrotic remodeling.

Molecular Imaging of Hepatic Stellate Cell Activity by Visualization of Hepatic Integrin Αvβ3 Expression with SPECT in Rat

Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ3 for staging liver fibrosis in rat model

Enhanced US/CT/MR imaging of integrin αvβ3 for liver fibrosis staging in rat

Small-Animal SPECT/CT of the Progression and Recovery of Rat Liver Fibrosis by Using an Integrin Αvβ3-Targeting Radiotracer.

Expression of integrin avβ3 in hepatic stellate cells and fibrotic liver tissue

Integrin Α6 Targeted Near Infrared Fluorescent Imaging and Photoacoustic Imaging of Hepatocellular Carcinoma in Mice

Non-invasively Differentiate Non-Alcoholic Steatohepatitis by Visualizing Hepatic Integrin Αvβ3 Expression with a Targeted Molecular Imaging Modality

Non-invasively Differentiating Extent of Liver Fibrosis by Visualizing Hepatic Integrin Αvβ3 Expression with an MRI Modality in Mice

Integrin-Targeted Theranostic Nanoparticles for Clinical MRI-Traceable Treatment of Liver Fibrosis

Assessment of Liver Fibrosis Using Pharmacokinetic Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

[18F]AlF-ND-bisFAPI PET imaging of fibroblast activation protein as a biomarker to monitor the progression of liver fibrosis

Small-animal SPECT/CT Imaging of Cancer Xenografts and Pulmonary Fibrosis Using a 99m Tc-labeled Integrin Αvβ6-Targeting Cyclic Peptide with Improved in Vivo Stability

Molecular Imaging of Tumor Angiogenesis Using Rgd-Labeled Iron Oxide Nanoparticles

Expression of Αvβ3 Integrin and Platelet-Endothelial Cell Adhesion Molecule-1 in Progressive Liver Fibrosis: Experiment with Rats

C1q/tumor Necrosis Factor-Related Protein-3 Acts As a Target Treating Hepatic Fibrosis

Preliminary study of molecular imaging of human hepatocellular carcinoma xenograft with Gd-based MR probe containing arginine-glycine-aspartic acid chelate

Therapeutic Effect and Location of GFP-Labeled Placental Mesenchymal Stem Cells on Hepatic Fibrosis in Rats

Efficacy of Ultrasound Microbubble-HGF Complex for Treating Hepatic Fibrosis and Its Relation with Perfusion Weighted Imaging

Assessment of Liver Fibrosis by Variable Flip Angle T-1 Mapping at 3.0T

The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model: An experimental study

Assessment and integration of multiparametric MRI for liver fibrosis staging in rat non-alcoholic steatohepatitis: Evaluation of diagnostic efficiency and model interpretation